| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c17612db7d98bb4baf5d622f5250492 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-327 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-32 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-327 |
| filingDate |
1980-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e649141e55954f7dc1c82349f27ce68f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a172285e8e14d0fb530481eb53d7d26 |
| publicationDate |
1980-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0016703-A1 |
| titleOfInvention |
Lysine salt of (+/-) 3-amino-4-(1-pyrrolyl)-alpha-methylphenyl-acetic acid, process for its preparation and pharmaceutical composition containing it |
| abstract |
The invention. relates to a salt of (±) amino-3 (pyrrolyl-1) -4-α-methyl phenyl acetic acid. This soluble salt is the lysine salt of the said acid, it is represented by the formulan n n n n n n n n n This new compound can be used as an analgesic and anti-inflammatory drug. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0324402-A1 |
| priorityDate |
1979-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |